×

Free to view

Evaluation of the incidence of bleeding in patients prescribed rivaroxaban for the treatment and prevention of deep vein thrombosis and pulmonary embolism in UK secondary care: an observational cohort study

  • Author

    Alison Evans Miranda Davies Vicki Osborne Debabrata Roy Saad Shakir

    Alison Evans, Miranda Davies, Vicki Osborne, Debabrata Roy, Saad Shakir

  • Cite

    BMJ Open 2020;10:e038102. doi: 10.1136/bmjopen-2020-038102

Free to view

Postmarketing studies: can they provide a safety net for COVID-19 vaccines in the UK?

  • Author

    Sandeep Dhanda Vicki Osborne Elizabeth Lynn Saad Shakir

    Sandeep Dhanda, Vicki Osborne, Elizabeth Lynn, Saad Shakir

  • Cite

    BMJ Evidence-Based Medicine Published Online First: 21 October 2020. doi: 10.1136/bmjebm-2020-111507

Free to view

Incidence of major and clinically relevant non-major bleeding in patients prescribed rivaroxaban for stroke prevention in non-valvular atrial fibrillation in secondary care: Results from the Rivaroxaban Observational Safety Evaluation (ROSE) study

  • Author

    Alison Evans Miranda Davies Vicki Osborne Debabrata Roy Saad Shakir

    Alison Evans, Miranda Davies, Vicki Osborne, Debabrata Roy, Saad Shakir

  • Cite

    PLoS ONE October 2020 15(10): e0240489. https://doi.org/10.1371/journal.pone.0240489

Free to view

Observational assessment of safety in seroquel (OASIS): a specialist cohort event monitoring (SCEM) study in England

  • Author

    Vicki Osborne Miranda Davies Alison Evans Saad A. W. Shakir

    Vicki Osborne, Miranda Davies, Alison Evans, Saad Shakir

  • Cite

    Therapeutic Advances in Psychopharmacology. January 2020. https://doi.org/10.1177/2045125320954616

Free to view

Lopinavir-Ritonavir in the Treatment of COVID-19: A Dynamic Systematic Benefit-Risk Assessment

  • Author

    Vicki Osborne Miranda Davies Samantha Lane Alison Evans Jacqueline Denyer Sandeep Dhanda Debabrata Roy Saad Shakir

    Vicki Osborne, Miranda Davies, Samantha Lane, Alison Evans, Jacqueline Denyer, Sandeep Dhanda, Debabrata Roy, Saad Shakir

  • Cite

    Drug Safety. 2020. https://doi.org/10.1007/s40264-020-00966-9

Free to view

Remdesivir in Treatment of COVID‑19: A Systematic Benefit–Risk Assessment

  • Author

    Miranda Davies Vicki Osborne Samantha Lane Debabrata Roy Sandeep Dhanda Alison Evans Saad Shakir

    Miranda Davies, Vicki Osborne, Samantha Lane, Debabrata Roy, Sandeep Dhanda, Alison Evans, Saad Shakir

  • Cite

    Drug Safety. 2020. https://doi.org/10.1007/s40264-020-00952-1

Free to view

The UK BIO-TRAC Study: A Cross-Sectional Study of Product and Batch Traceability for Biologics in Clinical Practice and Electronic Adverse Drug Reaction Reporting in the UK

  • Author

    Kevin Klein Lorna Hazell Pieter Stolk Saad Shakir

    Kevin Klein, Lorna Hazell, Pieter Stolk, Saad Shakir

  • Cite

    Drug Safety. 2020 March, 43, 255–263 https://doi.org/10.1007/s40264-019-00891-6

Free to view

Rationale and design of a European epidemiological post-authorization safety study (PASS) program: rivaroxaban use in routine clinical practice

  • Author

    Luis Alberto García-Rodríguez  Mari-Ann Wallander Leif Friberg Ana Ruigomez Tania Schink Irene Bezemer Ron Herings Saad Shakir Alison Evans Miranda Davies Kiliana Suzart-Woischnik Pareen Vora Yanina Balabanova Montse Soriano-Gabarró Gunnar Brobert

    Luis Alberto García-Rodríguez , Mari-Ann Wallander, Leif Friberg, , Tania Schink, Irene Bezemer, Ron Herings, Saad Shakir, Alison Evans, Miranda Davies, Kiliana Suzart-Woischnik, Pareen Vora, Yanina Balabanova, Montse Soriano-Gabarró, Gunnar Brobert

  • Cite

    Expert Opinion on Drug Safety 2020, DOI: 10.1080/14740338.2020.1798928

Free to view

Systematic benefit-risk assessment for buprenorphine implant: a semiquantitative method to support risk management

  • Author

    Vicki Osborne Miranda Davies Debabrata Roy Francesco Tescione  Saad A W Shakir

    Vicki Osborne, Miranda Davies, Debabrata Roy, Francesco Tescione , Saad Shakir

  • Cite

    BMJ Evidence-Based Medicine Published Online First: 24 February 2020. doi: 10.1136/bmjebm-2019-111295

First Conference on Big Data for Pharmacovigilance

  • Author

    Jae Min Vicki Osborne Elizabeth Lynn Saad A W Shakir

    Jae Min, Vicki Osborne, Elizabeth Lynn, Saad Shakir

  • Cite

    Drug Saf. 2018 Dec;41(12):1281-1284. doi: 10.1007/s40264-018-0727-2

Safety of Atrovent® CFC-free inhaler: respiratory events reported from an observational cohort study in England.

  • Author

    Vicki Osborne Deborah Layton Carole Fogg Edward Tong Saad A W Shakir

    Vicki Osborne, Deborah Layton, Carole Fogg, Edward Tong, Saad Shakir

  • Cite

    Int J Pharm Pract. 2018 Aug;26(4):356-363

Utilisation and Safety of Deferasirox: Results from an Observational Cohort Study in England.

  • Author

    Vicki Osborne Miranda Davies Deborah Layton Saad A W Shakir

    Vicki Osborne, Miranda Davies, Deborah Layton, Saad Shakir

  • Cite

    Drug Safety 2018 Mar;41(3):267-275.

Free to view

Investigation assessing the publicly available evidence supporting postmarketing withdrawals, revocations and suspensions of marketing authorisations in the EU since 2012.

  • Author

    Samantha Lane Elizabeth Lynn Saad Shakir

    Samantha Lane, Elizabeth Lynn, Saad Shakir

  • Cite

    BMJ Open 2018;8:e019759. doi: 10.1136/bmjopen-2017-019759

The 9th Biennial Conference on Signal Detection and Interpretation in Pharmacovigilance.

  • Author

    Vicki Osborne Saad A W Shakir

    Vicki Osborne, Saad Shakir

  • Cite

    Drug Saf. 2018 Jan;41(1):139-141

Drugs and life-threatening ventricular arrhythmia risk: results from the DARE study cohort.

  • Author

    Abigail L Coughtrie Elijah R Behr Deborah Layton Vanessa Marshall A John Camm Saad A W Shakir

    Abigail Coughtrie, Elijah Behr, Deborah Layton, Vanessa Marshall, John Camm, Saad Shakir

  • Cite

    BMJ Open. 2017 Oct 16;7(10):e016627.

Evidence for the hERG Liability of Antihistamines, Antipsychotics, and Anti-Infective Agents: A Systematic Literature Review From the ARITMO Project.

  • Author

    Lorna Hazell Emanuel Raschi Fabrizio De Ponti Simon H L Thomas Francesco Salvo Ernst Ahlberg Helgee Scott Boyer Miriam Sturkenboom Saad Shakir

    Lorna Hazell, Emanuel Raschi, Fabrizio De Ponti, Simon Thomas, Francesco Salvo, Ernst Ahlberg Helgee, Scott Boyer, Miriam Sturkenboom, Saad Shakir

  • Cite

    J Clin Pharmacol. 2017 May;57(5):558-572

Use of atomoxetine and suicidal ideation in children and adolescents: Results of an observational cohort study within general practice in England.

  • Author

    M Davies A Coughtrie D Layton S A S Shakir

    Miranda Davies, Abigail Coughtrie, Deborah Layton, Saad Shakir

  • Cite

    Eur Psychiatry. 2017 Jan;39:11-16.

Utilisation and Tolerability of Aliskiren in the Primary Care Setting in England.

  • Author

    Abigail L Coughtrie Claire Doe Deborah Layton Saad A W Shakir

    Abigail Coughtrie, Claire Doe, Deborah Layton, Saad Shakir

  • Cite

    J Clin Hypertens (Greenwich). 2016 Dec;18(12):1237-1243

Pattern of Onset and Risk Factors for Peripheral Oedema During Vildagliptin Use: Analysis from the Vildagliptin Prescription-Event Monitoring Study in England.

  • Author

    Deborah Layton Abigail L. Coughtrie Naseer Qayum Saad A. W. Shakir

    Deborah Layton, Abigail Coughtrie, Naseer Qayum, Saad Shakir

  • Cite

    Drug Safety 2016 Nov;39(11):1093-1104.

Free to view

Safety of Intranasal Quadrivalent Live Attenuated Influenza Vaccine (QLAIV) in Children and Adolescents: A Pilot Prospective Cohort Study in England

  • Author

    Rhian McNaughton Elizabeth Lynn Vicki Osborne Abigail Coughtrie Deborah Layton Saad Shakir

    Rhian McNaughton, Elizabeth Lynn, Vicki Osborne, Abigail Coughtrie, Deborah Layton, Saad Shakir

  • Cite

    Drug Safety. April 2016, Volume 39, Issue 4, pp 323–333

Free to view

Vulnerable Patients and Potential Harms: The Contribution of Observational Research.

  • Author

    Deborah Layton

    Deborah Layton

  • Cite

    Drug Safety. April 2016, Volume 39, Issue 4, pp 277–280.

Utilisation of extended release quetiapine (Seroquel XL™): Results from an observational cohort study in England.

  • Author

    V Osborne M Davies D Layton S A W Shakir

    Vicki Osborne, Miranda Davies, Deborah Layton, Saad Shakir

  • Cite

    Eur Psychiatry. 2016 Mar;33:61-7

Sudden cardiac and sudden unexpected death related to antipsychotics: A meta-analysis of observational studies

  • Author

    F Salvo A Pariente S Shakir P Robinson M Arnaud Shl Thomas E Raschi A Fourrier-Réglat N Moore M Sturkenboom L Hazell On Behalf Of Investigators Of The Aritmo Consortium Investigators of the ARITMO Consortium

    Francesco Salvo, Antoine Pariente, Saad Shakir, Philip Robinson, Mickael Arnaud, Simon Thomas, Emanuel Raschi, Annie Fourrier-Réglat, Nicholas Moore, Miriam Sturkenboom, Lorna Hazell,

  • Cite

    Clin Pharmacol Ther. 2016 Mar;99(3):306-14

Contribution of UK Prescription-Based Event Monitoring Methods in the Pharmacovigilance of Psychotropic Medications

  • Author

    Deborah Layton

    Deborah Layton

  • Cite

    Chapter in "Pharmacovigilance in Psychiatry", 2016, edited by Edoardo Spina and Gianluca Trifirò, published by ADIS

Free to view

The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project.

  • Author

    Emanuel Raschi Elisabetta Poluzzi Francesco Salvo Ariola Koci Marc Suling Stefania Antoniazzi Luisella Perina Lorna Hazell Ugo Moretti Miriam Sturkenboom Edeltraut Garbe Antoine Pariente Fabrizio De Ponti

    Emanuel Raschi, Elisabetta Poluzzi, Francesco Salvo, Ariola Koci, Marc Suling, Stefania Antoniazzi, Luisella Perina, Lorna Hazell, Ugo Moretti, Miriam Sturkenboom, Edeltraut Garbe, Antoine Pariente, Fabrizio De Ponti

  • Cite

    Drug Safety 2016 Jan Volume39(1):59–68